Abstract:Dendritic cells (DCs) are the most potent antigen presenting cells and possess an incomparable ability to activate and instruct T cells, which makes them one of the cornerstones in the regulation of the cross-talk between innate and adaptive immunity. Therefore, a deep understanding of DC biology lays the foundations to describe and to harness the mechanisms that regulate the development of the adaptive response, with clear implications in a vast array of fields such as the study of autoimmune diseases and the development of new vaccines. However, the great difficulty to obtain large quantities of viable non-activated DCs for experimentation have considerably hindered the progress of DC research. Several strategies have been proposed to overcome these limitations by promoting an increase of DC abundance in vivo, by inducing DC development from DC progenitors in vitro and by generating stable DC lines. In the past years, we have described a method to derive immortalized stable DC lines, named MutuDCs, from the spleens of Mushi1 mice, a transgenic mouse strain that express the simian virus 40 Large T-oncogene in the DCs. The comparison of these DC lines with the vast variety of DC subsets described in vivo has shown that all the MutuDC lines that we have generated so far have phenotypic and functional features of type 1 conventional DCs (cDC1s). With the purpose of deriving DC lines with characteristics of type 2 conventional DCs (cDC2s), we bred a new Batf3-/- Mushi1 murine line in which the development of the cDC1 subset is severely defective. The new MutuDC line that we generated from Batf3-/- Mushi1 mice was phenotypically and functionally characterized in this work. Our results demonstrated that all the tested characteristics of this new cell line, including the expression of subset-determining transcription factors, the profile of cytokine production and the ability to present antigens, are comparable with the features of splenic CD4- cDC2s. Therefore, we concluded that our new cell line, that we named CD4- MutuDC2 line, represents a valuable model for the CD4- cDC2 subset.

Distinct ontogenetic lineages dictate cDC2 heterogeneity

Ly6D+Siglec-H+ precursors contribute to conventional dendritic cells via a Zbtb46+Ly6D+ intermediary stage

pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T cells

Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor

Origin, precursors and differentiation of mouse dendritic cells

Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity

Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity

Distinct functional capacities of mouse thymic and splenic dendritic cell populations

Human dendritic cell subsets: an update

Bifurcated Dendritic Cell Differentiation in Vitro from Murine Lineage Phenotype-Negative C-Kit(+) Bone Marrow Hematopoietic Progenitor Cells

Clec12A, CD301b, and FcγRIIB/III define the heterogeneity of murine DC2s and DC3s

Notch2-dependent DC2s mediate splenic germinal center responses

Development of Plasmacytoid and Conventional Dendritic Cell Subtypes from Single Precursor Cells Derived in Vitro and in Vivo

Phenotypic and functional differences of dendritic cells in tumor

Dendritic cell type 3 arises from Ly6C+ monocyte-dendritic cell progenitors

Single-Cell Analysis Reveals the Heterogeneity of Monocyte-Derived and Peripheral Type-2 Conventional Dendritic Cells

A new step in understanding mouse cDC ontogeny

Development of Thymic and Splenic Dendritic Cell Populations from Different Hemopoietic Precursors

Mapping the human DC lineage through the integration of high-dimensional techniques

Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell Line

Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages.